IBL HealthCare Limited (IBLHL): FY24 Corporate Briefing Takeaways - By Taurus Research
Feb 27 2025
Taurus Securities
- IBL Healthcare Pakistan, a leading player in the healthcare and wellness industry, operates across diverse segments, including Nutrition, Health & Wellness, Ophthalmic, Medical Disposables, and Pharmaceuticals. Despite facing challenges in FY24, including supply chain constraints and plant shutdowns, the Company continues to focus on strategic growth and product innovation.
- IBL Healthcare reported a 11%YoY decline in revenue, totaling ~PKR 3.6Bn in FY24, down from ~PKR 4.0Bn in FY23. This was mainly attributed to supply chain disruptions caused by the plant shutdown of Mead Johnson in Thailand.
- The Company’s profit significantly reduced to ~PKR 7.6Mn (EPS: PKR 0.09) in FY24, compared to PKR 309Mn (EPS: PKR 3.61) in FY23. This decline was driven by discounts offered due to the limited shelf life of food products.
Current:
Open:
Volume:
Change: ()
High:
Low:
52 Week High:
Vol Avg(12 m):
Free Float:
52 Week Low:
Market Cap:
Total Share:
Relative Strength Index (RSI)
RSI:
MACD Signals
MACD DAILY:
MACD WEEKLY:
Simple Moving Avg (SMA)
SMA(10):
SMA(30):
SMA(60):
SMA(200):
Performance
One Month:
Three Months:
Six Months:
Twelve Months:
Support & Resistance
Support 1:
Resistance 1:
Support 2:
Resistance 2:
High & Lows
Period
High
Low